Medicines UK Welcomes NHS England’s Best-Value Biologics Biosimilar Adoption Framework
Switching To Biosimilars From Five Select Biologics Could Save Over $1bn
Reflecting on recent initiatives by NHS England and the MHRA, the newly renamed trade body Medicines UK has welcomed efforts in promoting the use of biosimilars in Britain.
